Cinacalcet Tablet, Film Coated
Product Images NDC 47335-600

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 47335-600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cinacalcet-chemical-structure (Cinacalcet Chemical Structure)

Chemical structure diagram of cinacalcet hydrochloride, showing its molecular framework including aromatic rings, an amine group, and trifluoromethyl substitutions.*

FDA Label Image

Cinacalcet-figure-2 (Cinacalcet Figure 2)

A line graph titled 'Mean (SE) Ca x P Values (Pooled Phase 3 Studies)' showing calcium-phosphorus product (Ca x P) levels in mg/dL squared over 26 weeks. The graph compares placebo (open circles) and Cinacalcet (filled circles) groups, with Ca x P values generally higher in placebo and decreasing over time in the Cinacalcet group.*

FDA Label Image

Cinacalcet-figure-3 (Cinacalcet Figure 3)

A line graph titled "Serum Calcium Values in Patients With Parathyroid Carcinoma Receiving Cinacalcet at Baseline, Titration, and Maintenance Phase" shows calcium levels in mg/dL on the y-axis and weeks on the x-axis. The graph tracks serum calcium from baseline, through titration, to maintenance phase over 80 weeks, with patient counts listed below corresponding to each time point.*

FDA Label Image

Cincalcet-figure-1 (Cincalcet Figure 1)

A line graph titled 'Mean (SE) iPTH Values (Pooled Phase 3 Studies)' compares iPTH levels (pg/mL) over 26 weeks between placebo and Cinacalcet treatment groups. The x-axis represents weeks from 0 to 26, and the y-axis shows iPTH values ranging from 0 to 1000 pg/mL. The Cinacalcet group shows a steady decrease in iPTH levels, while the placebo group remains relatively stable.*

FDA Label Image

Spl-cinacalcet-figure-4 (Spl Cinacalcet Figure 4)

A line graph showing calcium levels (mg/dL) over weeks from baseline (B) through titration and maintenance phases. Calcium levels start high at baseline, drop sharply by the end of titration (EOT), then remain relatively stable with slight fluctuations through week 80. The number of subjects with intractable pHPT is indicated below the x-axis at various time points.*

FDA Label Image

Spl-cinacalcet-label-30mg (Spl Cinacalcet Label 30mg)

Label for Cinacalcet Tablets 30 mg film-coated oral tablets by Sun Pharmaceutical Industries, Inc. The label indicates prescription-only status, contains 30 tablets, and includes the NDC 47335-379-83 with a barcode.*

FDA Label Image

Spl-cinacalcet-label-60mg (Spl Cinacalcet Label 60mg)

Label for Cinacalcet Tablets 60 mg film-coated tablets. The label shows the strength as 60 mg and indicates a quantity of 30 tablets. It is labeled for prescription use only and includes the Sun Pharmaceutical Industries, Inc. logo. The National Drug Code (NDC) is 47335-380-83 and the label features a barcode.*

FDA Label Image

Spl-cinacalcet-label-90mg (Spl Cinacalcet Label 90mg)

Cinacalcet Tablets 90 mg film-coated oral tablet label by Sun Pharmaceutical Industries, Inc. The label includes dosage strength (90 mg), quantity (30 tablets), storage instructions, and manufacturer information for Sun Pharmaceutical Industries Limited, India. The NDC number is 47335-600-83.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.